Radhakrishnan Maha has filed 4 insider transactions across 3 companies since March 2024.
Most recent transaction: a grant/award of 28480 shares of Candel Therapeutics, Inc. ($CADL) on June 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 4, 2025 | Candel Therapeutics, Inc. | $CADL | Radhakrishnan Maha | Not found | A | Stock Option (Right to Buy) | 28480 | $0.00 | 28,480.0000 | 46,933,088 | 9999.99% | 0.06% |
| June 1, 2025 | Entrada Therapeutics, Inc. | $TRDA | Radhakrishnan Maha | Director | A | Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 39,003,169 | 9999.99% | 0.10% |
| March 8, 2024 | Alto Neuroscience, Inc. | $ANRO | Radhakrishnan Maha | Not found | A | Stock Option (right to buy) | 30574 | $0.00 | 30,574.0000 | 0 | 9999.99% | 0.00% |
| March 8, 2024 | Alto Neuroscience, Inc. | $ANRO | Radhakrishnan Maha | Not found | A | Stock Option (right to buy) | 1590 | $10.21 | 1,590.0000 | 0 | 9999.99% | 0.00% |